Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by investclubon Mar 16, 2020 12:00pm

150 Views

Post# 30812850

Theralase Twitter

https://mobile.twitter.com/TheralaseTech

Ranked 8th in Clean Technology and Life Sciences, $TLT.V is utilizing the Anti-Cancer Technology ("ACT") for Non-Muscle Invasive #BladderCancer, a highly unmet medical need. An image of the Study Device emitting laser light energy to activate the Study Drug & destroy cancer.

11:40 AM · Mar 16, 2020·Twitter Web App

2

Likes

Home

See new Tweets

Your Home Timeline

Get the app

The Twitter app lets you see what’s happening, join the conversation, and watch live events, instantly.

Download now

Theralase Technologies (TSXV: TLT)

@TheralaseTech

·